נכסים נקיים למניה בודדת voyagertherapeutics.com (VYGR)

This chart from the GURU.Markets platform demonstrates the price action of Voyager Therapeutics (VYGR), a leader in developing TRACER systems for brain-targeted gene therapy delivery, where the key metric stands at 2.52. Production cycles for drug carrier development are proceeding on schedule at certified external sites, while Voyager Therapeutics (VYGR) minimizes costs by outsourcing vector manufacturing and testing to third-party partners.

Voyager Therapeutics dominates the brain gene therapy delivery segment thanks to unique technologies for crossing the blood-brain barrier. The book value per share trend reflects the remaining equity after all liabilities are settled, allowing investors to assess the real asset value per share and filter out issuers with a degrading fundamental base through the analysis of this chart.